H.R. 3206 · 112th Congress
Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 112th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
BurgessSponsor15 cosponsors · 2 D, 13 R
R
Bilbray
MB
R
Blackburn
BC
R
Cassidy
PG
R
Gingrey
BG
R
Guthrie
RL
R
Latta
EP
R
Paulsen
JS
R
Shimkus
JC
R
Culberson
GW
R
Walden
LB
R
Bucshon
MM
R
McCaul
TR
R
Rokita
JB
D
Barrow
JM
D
Matheson8 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011 - Amends the Federal Food, Drug, and Cosmetic Act to revise provisions related to financial interests of Food and Drug Administration (FDA) advisory committee members to require the Secretary of Health and Human Services (HHS) to ensure that individual appointments to advisory…
What it does: CRS summary · Introduced in House · Oct 14, 2011
Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011 - Amends the Federal Food, Drug, and Cosmetic Act to revise provisions related to financial interests of Food and Drug Administration (FDA) advisory committee members to require the Secretary of Health and Human Services (HHS) to ensure that individual appointments to advisory committees are made to promote scientific and technical expertise while at the same time minimizing any potential conflicts of interest. Requires the Secretary to consider, with respect to any financial interest constituting a potential conflict of interest, the type, nature, and magnitude of the financial interest. Declares that no specific factor shall be dispositive in the Secretary's evaluation of a particular financial interest.
Repeals the prohibition specifically applicable to FDA that prevents a member of an advisory committee from participating with respect to a particular matter if such individual or an immediate family member of such individual has a financial interest that could be affected by the advice given to the Secretary.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011
Latest action (Oct 18, 2011): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: Oct 14, 2011
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.